Chimerix, Inc. (CMRX)
NASDAQ: CMRX · Real-Time Price · USD
3.780
-0.060 (-1.56%)
Jan 22, 2025, 4:00 PM EST - Market closed
Chimerix Market Cap
Chimerix has a market cap or net worth of $339.96 million as of January 22, 2025. Its market cap has increased by 296.22% in one year.
Market Cap
339.96M
Enterprise Value
207.97M
1-Year Change
296.22%
Ranking
Category
Stock Price
$3.78
Market Cap Chart
Since April 11, 2013, Chimerix's market cap has decreased from $435.70M to $339.96M, a decrease of -21.97%. That is a compound annual growth rate of -2.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2025 | 345.40M | 10.35% |
| Dec 31, 2024 | 313.00M | 265.65% |
| Dec 29, 2023 | 85.60M | -47.74% |
| Dec 30, 2022 | 163.80M | -70.67% |
| Dec 31, 2021 | 558.50M | 84.63% |
| Dec 31, 2020 | 302.50M | 142.78% |
| Dec 31, 2019 | 124.60M | -4.45% |
| Dec 31, 2018 | 130.40M | -40.24% |
| Dec 29, 2017 | 218.20M | 2.39% |
| Dec 30, 2016 | 213.10M | -48.40% |
| Dec 31, 2015 | 413.00M | -71.88% |
| Dec 31, 2014 | 1.47B | 267.86% |
| Dec 31, 2013 | 399.20M | -8.38% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 677.34B |
| UnitedHealth Group | 478.13B |
| Novo Nordisk | 360.47B |
| Johnson & Johnson | 347.78B |
| AbbVie | 300.80B |
| Merck & Co. | 242.60B |
| Thermo Fisher Scientific | 220.38B |
| Intuitive Surgical | 218.24B |